Completed PHASE3 INTERVENTIONAL NCT00751504

Quetiapine in the Treatment of Psychotic Depression - a Pilot Study

Sponsor: Ruhr University of Bochum

Interventions Quetiapine

Updated 5 times since 2017 Last updated: Jan 23, 2013 Started: Sep 30, 2008 Primary completion: Jul 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Psychotic Depression, this trial is completed. The trial is conducted by Ruhr University of Bochum and has accumulated 5 data snapshots since 2008. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ruhr University of Bochum

Data source: Ruhr University of Bochum

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bochum, Germany